1. Do RARA/PML fusion gene deletions confer resistance to ATRA-based therapy in patients with acute promyelocytic leukemia? Subramaniyam, Shivakumar; Nandula, Subhadra; Nichols, G.; Weiner, Michael A.; Satwani, Prakash; Alobeid, Bachir; Bhagat, Govind; Vundavalli, Murty V. 2006 Articles LeukemiaLeukemia--TreatmentDrug resistance in cancer cellsGene fusionGenetics
2. CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to c-secretase inhibitors Palomero, Teresa; Barnes, K. C.; Real, P. J.; Glade Bender, Julia L.; Sulis, Maria-Luisa; Vundavalli, Murty V.; Colovai, Adriana I.; Balbin, M.; Ferrando, Adolfo A. 2006 Articles Lymphoblastic leukemiaT cells--ResearchGeneticsCancer--TreatmentPathology
3. Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21 Li, Chi-Ming; Guo, Meirong; Salas, Martha; Schupf, Nicole; Silverman, Wayne; Zigman, Warren; Husain, Sameera; Warburton, Dorothy P.; Thaker, Harshwardhan; Tycko, Benjamin 2006 Articles Gene expressionDown syndromeGeneticsCytology